BXP, the consistently growing, profitable, cash and stock dividend issuing generic pharmaceuticals manufacturer gave a market update on 17 June 2016, stating that it has started to export to Kuwait, which is a first for any Bangladeshi pharmaceutical company into the Gulf region. The Gulf market is mentioned to be worth as much as $9 billion, with the Kuwait market alone coming in at ~$1.5 billion.
So here begins a series of blogs which have very little, if at all, to do with investing, but with music instead. I love music and I would sooner be sat in a corner listening to the efforts of artists that I will never know, for hours on end rather than spending time with random people trying to get me to notice them and include them in my life.
Northern Bear (NTBR) Gave a trading update last week which suggested that the earnings per share for its latest full year will be in line with the previous year’s earnings (8.5p per share) and management’s expectations. NTBR has spent most of the last 5 years sitting with a PE ratio below 5.
Beximco Pharmaceuticals (BXP) The consistently growing, profitable, cash and stock dividend issuing generic pharmaceuticals manufacturer recently announced its full year results to 31 December 2015, including some of the following highlights:
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.